Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic
- 1 December 2002
- journal article
- clinical trial
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 22 (12) , 1533-1540
- https://doi.org/10.1592/phco.22.17.1533.34127
Abstract
Objective. To determine whether pharmaceutical care provided by a pharmacist‐managed hypertension clinic results in better treatment outcomes when compared with traditional health care from a primary care physician.Design. Prospective, controlled study.Setting. Veterans Affairs Medical Center, Philadelphia, Pennsylvania.Patients. Fifty six patients with essential hypertension; 27 were randomly assigned to the intervention group and 29 to the control group.Intervention. Patients in the intervention group were scheduled monthly to meet with a clinical pharmacist who made appropriate changes in prescribed drugs, adjusted dosages, and provided drug counseling in accordance with the hypertension guidelines in the sixth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Patients in the control group received standard care from their physicians. The study period was 6 months.Measurements and Main Results. Treatment outcomes were measured by changes in compliance, blood pressure, and patient satisfaction. The Short Form‐36 health survey and a patient satisfaction survey were used to measure changes in patient satisfaction, and a compliance evaluation survey measured compliance. Twenty‐one (81%) patients in the intervention group attained their blood pressure goal of below 140/90 mm Hg at the completion of the study versus only eight (30%) in the control group (pConclusions. Pharmaceutical care improves blood pressure control and results in more patients with hypertension reaching their blood pressure goal.Keywords
This publication has 12 references indexed in Scilit:
- Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centersAmerican Journal of Health-System Pharmacy, 1998
- The IMPROVE study: Background and study designAmerican Journal of Health-System Pharmacy, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- End-stage Renal Disease in African-American and White MenJAMA, 1997
- Prevalence of Hypertension in the US Adult PopulationHypertension, 1995
- Blood Pressure, Systolic and Diastolic, and Cardiovascular RisksArchives of internal medicine (1960), 1993
- Combined α/β-blockade versus β1-selective blockade in essential hypertension in black and white patientsClinical Pharmacology & Therapeutics, 1990
- Impact of race on treatment response and cardiovascular disease among hypertensives.Hypertension, 1989
- The MOS Short-form General Health SurveyMedical Care, 1988
- Five-year findings of the Hypertension Detection and Follow-up ProgramJournal of Community Health, 1984